Pathophysiological subtypes of mild cognitive impairment due to Alzheimer's disease identified by CSF proteomics

Affiliations

• ¹ Faculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
• ² CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.
• ³ CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.
• ⁴ LASIGE, Faculty of Sciences, University of Lisbon, 1649-028, Lisbon, Portugal.
• ⁵ Biocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
• ⁶ Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
• ⁷ Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, S-431 80, Mölndal, Sweden.
• ⁸ Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, S-431 80, Mölndal, Sweden.
• ⁹ Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
• ¹⁰ Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.
• ¹¹ Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin, University of Wisconsin-Madison, Madison, WI, 53792, USA.
• ¹² UK Dementia Research Institute at UCL, London, WC1N 3BG, UK.
• ¹³ Department of Neurology, Hospital and University Centre of Coimbra, Coimbra, Portugal.
• ¹⁴ CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal. bmanadas@cnc.uc.pt.
• ¹⁵ CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal. bmanadas@cnc.uc.pt.